McGovern, V.J. : Reactions to injury of vascular endothelium with special reference to the problem of thrombosis. J. Pathol. Bacteriol., 69: 283, 1955.
2.
Zugibe, F.T. : The demonstration of the individual acid mucopolysaccharides in human aortas, coronary arteries and cerebral arteries. J. Histochem. Cytochem., 10: 448, 1962.
3.
Ohta, G., Sasaki, H., Matsubara, F., et al.: Heparin-like substances in cement lines of vascular endothelium of guinea pigs. Proc. Soc. Exp. Biol. Med., 109: 298, 1962.
4.
Velican, C.: Topochemistry of acid carbohydrates in the human aortic and coronary intima . J. Ather. Res.,7: 517, 1967.
5.
Marin, H.M., White, H.S.: Anti-coagulant activity of acidic mucopolysaccharides of the vascular wall . Fed. Proc., 22: 619, 1963.
6.
Buonassi, V. : Sulfated mucopolysaccharide synthesis and secretion in endothelial cell cultures. Exp. Cell Res., 76: 363, 1973.
7.
Buonassi, V. : Enzymatic degradation of heparin-related mucopolysaccharides from the surface of endothelial cell cultures. Biochim. Biophys. Acta, 385: 1, 1975.
8.
Adkins, E.D.T. , Nieduszynski, I.A.: Effect of an alpha-L-iduronate conformation on the molecular shape of heparin. Fed. Proc., 36: 78, 1977.
9.
Jaques, L.B. : The pharmocology of heparin and heparinoids . Prog. Medi. Chem.,5: 139, 1967.
10.
McGovern, V.J. : Mast cells and their relationship to endothelial surfaces. J. Pathol. Bacteriol., 71: 1, 1956.
11.
Samuels, P.B. , Webster, D.R.: The role of venous endothelium in the inception of thrombosis. Ann. Surg., 136: 422, 1952.
12.
Srinivasan, S., Aaron, R., Chopra, P.S., et al.: Effect of thrombotic and antithrombotic drugs on the surface charge characteristics of canine blood vessels. Surgery, 64: 827, 1968.
13.
Hiebert, L.M. , Jaques, L.B.: The observation of heparin on endothelium after injection. Thromb. Res., 8: 195, 1976.
Caen, J.P., David, K., Lagrand, Y.J.: Dynamics of Thrombus Formation and Dissolution. Lippincott , Philadelphia, 1969, p. 95.
26.
Essien, E.M. , Kinbrough-Rathbone , R., Moore, S., et al.: The role of heparin on the inhibition of platelet adhesion to damaged arterial endothelial surface. Thromb. Diath. Hem.34: 600, 1975.
27.
Lagergren, H., Larsson, R., Olsson, P., Radegran, K., Swedenborg, J.: Decreased platelet adhesion as a characteristic of non-thrombogenic heparinized polymer surfaces. Thromb. Diath. Haemorrh.,34: 557, 1975.
28.
Astrup, T., Albrechtsen, O.K., Claassen, M., et al.: Thromboplastic and fibrinolytic activity of the human aorta . Circ. Res., 7: 969, 1959.
29.
Lyford, C.L. , Connor, W.E., Hoak, J.C., et al.: The coagulant and thrombogenic properties of human atheroma. Circulation, 36: 284, 1967.
30.
Bloom, A.L. , Giddings, J.C., Wilks, C.J., et al.: Immunohistological localization of coagulation factors on vascular intima. Br. J. Haematol. , 25: 275, 1973.
31.
Lough, J., Moore, S.: Endothelial injury induced by thrombin or thrombi. Lab. Invest. , 33: 130, 1975.
32.
Sawyer, P.N. , Suckling, E.E., Wesolowski, S.A.: Effect of small currents on intravascular thrombosis in the visualized rat mesentery. Am. J. Physiol. , 198: 1006, 1960.
33.
Robertson, A.L., Jr.: Effects of heparin on the uptake of lipids by isolated human and animal arterial endothelial cell types. Angiology,12: 525, 1961.
34.
Brown, M.S. , Goldstein, J.L.: Receptor-mediated control of cholesterol metabolism. Science, 191: 150, 1976.
35.
Day, C.E., Powell, J.R., Levy, R.S.: Sulfated polysaccharide inhibition of aortic uptake of low density lipoproteins . Artery,1: 126, 1974-75.
36.
Engelberg, H., Kuhn, R., Steinman, M.: A controlled study of the effect of intermittent heparin therapy on the course of human coronary atherosclerosis. Circulation, 13: 489, 1956.
37.
Bottiger, L.E. , Carlson, L.A., Engstedt, L., et al.: Long-term heparin treatment in ischemic heart disease. Effects on clinical condition and plasma lipids. Acta Med. Scand., 182: 245, 1967.